{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:40:16Z","timestamp":1777394416070,"version":"3.51.4"},"reference-count":66,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2016,8,3]]},"DOI":"10.3233\/jad-160320","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T11:37:43Z","timestamp":1470310663000},"page":"1079-1096","source":"Crossref","is-referenced-by-count":44,"title":["Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"53","author":[{"given":"Yannick","family":"Vermeiren","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Wilrijk (Antwerp), Belgium"},{"name":"Department of Neurology and Alzheimer Research Center, University of Groningen and University Medical Center Groningen (UMCG), Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Janssens","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Wilrijk (Antwerp), Belgium"},{"name":"Department of Neurology and Alzheimer Research Center, University of Groningen and University Medical Center Groningen (UMCG), Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Aerts","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Wilrijk (Antwerp), Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Jacques","family":"Martin","sequence":"additional","affiliation":[{"name":"Biobank, Institute Born-Bunge, University of Antwerp, Wilrijk (Antwerp), Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Sieben","sequence":"additional","affiliation":[{"name":"Biobank, Institute Born-Bunge, University of Antwerp, Wilrijk (Antwerp), Belgium"},{"name":"Department of Neurology, University Hospital Ghent and University of Ghent, Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debby","family":"Van Dam","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Wilrijk (Antwerp), Belgium"},{"name":"Department of Neurology and Alzheimer Research Center, University of Groningen and University Medical Center Groningen (UMCG), Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter P.","family":"De Deyn","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, University of Antwerp, Wilrijk (Antwerp), Belgium"},{"name":"Department of Neurology and Alzheimer Research Center, University of Groningen and University Medical Center Groningen (UMCG), Groningen, The Netherlands"},{"name":"Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium"},{"name":"Biobank, Institute Born-Bunge, University of Antwerp, Wilrijk (Antwerp), Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-160320_ref1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/WAD.0b013e3182a7159d","article-title":"Demographic and neuropsychiatric factors associated with off-label medication use in frontotemporal dementia and Alzheimer\u2019s disease","volume":"28","author":"Tartaglia","year":"2014","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-160320_ref2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1212\/01.wnl.0000191304.55196.4d","article-title":"A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia","volume":"66","author":"Huey","year":"2006","journal-title":"Neurology"},{"key":"10.3233\/JAD-160320_ref3","first-page":"297","article-title":"Frontotemporal lobar degeneration: Current perspectives","volume":"10","author":"Riedl","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.3233\/JAD-160320_ref4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00213-007-0992-8","article-title":"Imbalance of a serotonergic system in frontotemporal dementia: Implication for pharmacotherapy","volume":"196","author":"Bowen","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.3233\/JAD-160320_ref5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00401-012-1029-x","article-title":"The genetics and neuropathology of frontotemporal lobar degeneration","volume":"124","author":"Sieben","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-160320_ref6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0197-4580(98)00086-4","article-title":"Decreased monoamine metabolites in frontotemporal dementia and Alzheimer\u2019s disease","volume":"19","author":"Sj\u00f6gren","year":"1998","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160320_ref7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jalz.2012.06.010","article-title":"Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia","volume":"9","author":"Vermeiren","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-160320_ref8","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.neuint.2007.10.018","article-title":"The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia","volume":"52","author":"Engelborghs","year":"2008","journal-title":"Neurochem Int"},{"key":"10.3233\/JAD-160320_ref9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1365-2125.1983.tb05876.x","article-title":"Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: Implications for the treatment of Parkinson\u2019s disease","volume":"15","author":"Jenner","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"10.3233\/JAD-160320_ref10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0022-3565(25)13049-8","article-title":"Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons","volume":"253","author":"Kelland","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3233\/JAD-160320_ref11","first-page":"172","article-title":"Preliminary neurochemical findings in non-Alzheimer dementia due to lobar atrophy","volume":"4","author":"Francis","year":"1993","journal-title":"Dementia"},{"key":"10.3233\/JAD-160320_ref12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13195-015-0096-3","article-title":"Principles and management of neuropsychiatric symptoms in Alzheimer\u2019s dementia","volume":"7","author":"Nowrangi","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-160320_ref13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13195-014-0090-1","article-title":"The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer\u2019s disease","volume":"7","author":"Vermeiren","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-160320_ref14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jalz.2013.05.1775","article-title":"Addition of MHPG to Alzheimer\u2019s disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer\u2019s disease but not other dementias","volume":"10","author":"Herbert","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-160320_ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2009.06.008","article-title":"In vivo imaging of synaptic function in the central nervous system I. Movement disorders and dementia","volume":"204","author":"Nikolaus","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.3233\/JAD-160320_ref16","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00702-007-0636-5","article-title":"A review of the literature on neuroimaging of serotonergic function in Alzheimer\u2019s disease and related disorders","volume":"114","author":"Salmon","year":"2007","journal-title":"J Neural Transm"},{"key":"10.3233\/JAD-160320_ref17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00401-011-0839-6","article-title":"Neuropathological background of phenotypical variability in frontotemporal dementia","volume":"122","author":"Josephs","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-160320_ref18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/gps.1249","article-title":"The Middelheim Frontality Score: A behavioural assessment scale that discriminates frontotemporal dementia from Alzheimer\u2019s disease","volume":"20","author":"De Deyn","year":"2005","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-160320_ref19","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.3233\/JAD-160320_ref20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging - Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-160320_ref21","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/gps.1395","article-title":"Neuropsychiatric symptoms of dementia: Cross-sectional analysis from a prospective, longitudinal Belgian study","volume":"20","author":"Engelborghs","year":"2005","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-160320_ref22","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","article-title":"Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria","volume":"51","author":"Neary","year":"1998","journal-title":"Neurology"},{"key":"10.3233\/JAD-160320_ref23","unstructured":"American Psychiatric Association (2000) DSM-IV-TR: Diagnostic and Statistical Manual of Mental Disorders. (4th ed.) text revised, American Psychiatric Association, Washington DC."},{"key":"10.3233\/JAD-160320_ref24","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3233\/JAD-140309","article-title":"Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer\u2019s disease","volume":"41","author":"Vermeiren","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160320_ref25","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/j.neurobiolaging.2014.05.031","article-title":"Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer\u2019s disease","volume":"35","author":"Vermeiren","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160320_ref26","first-page":"9","article-title":"Behavioral symptoms in Alzheimer\u2019s disease: Phenomenology and treatment","volume":"48","author":"Reisberg","year":"1987","journal-title":"J Clin Psychiatry"},{"key":"10.3233\/JAD-160320_ref27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/geronj\/44.3.M77","article-title":"A description of agitation in a nursing home","volume":"44","author":"Cohen-Mansfield","year":"1989","journal-title":"J Gerontol"},{"key":"10.3233\/JAD-160320_ref28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0006-3223(88)90038-8","article-title":"Cornell Scale for Depression in Dementia","volume":"23","author":"Alexopoulos","year":"1988","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-160320_ref29","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1176\/ajp.139.9.1136","article-title":"The Global Deterioration Scale for assessment of primary degenerative dementia","volume":"139","author":"Reisberg","year":"1982","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JAD-160320_ref30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-160320_ref31","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer\u2019s disease-associated neurofibrillary pathology using paraffin sections and immunohistochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-160320_ref32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-3-7091-7508-8_8","article-title":"Neuropathology of Alzheimer\u2019s disease: A critical update","volume":"54","author":"Jellinger","year":"1998","journal-title":"J Neural Transm Suppl"},{"key":"10.3233\/JAD-160320_ref33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging; Alzheimer\u2019s Association: National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: A practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-160320_ref34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-007-0237-2","article-title":"Consortium for Frontotemporal Lobar Degeneration. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: Consensus of the Consortium for Frontotemporal Lobar Degeneration","volume":"114","author":"Cairns","year":"2007","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-160320_ref35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00401-008-0460-5","article-title":"Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: Consensus recommendations","volume":"117","author":"Mackenzie","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-160320_ref36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-009-0612-2","article-title":"Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: An update","volume":"119","author":"Mackenzie","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-160320_ref37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","article-title":"A harmonized classification system for FTLD-TDP pathology","volume":"122","author":"Mackenzie","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-160320_ref38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s12031-011-9551-1","article-title":"Novel types of frontotemporal lobar degeneration: Beyond tau and TDP-43","volume":"45","author":"Mackenzie","year":"2011","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-160320_ref39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.chroma.2014.05.004","article-title":"Novel and sensitive reversed-phase high-pressure liquid chromatography method with electrochemical detection for the simultaneous and fast determination of eight biogenic amines and metabolites in human brain tissue","volume":"1353","author":"Van Dam","year":"2014","journal-title":"J Chromatogr A"},{"key":"10.3233\/JAD-160320_ref40","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.neurobiolaging.2005.06.003","article-title":"Involvement of GABAergic system in depressive symptoms of Alzheimer\u2019s disease","volume":"27","author":"Garcia-Alloza","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160320_ref41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0893-133X(01)00393-1","article-title":"The human brain revisited: Opportunities and challenges in postmortem studies of psychiatric disorders","volume":"26","author":"Lewis","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.3233\/JAD-160320_ref42","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2990.2008.01003a.x","article-title":"pH measurement as quality control on human post mortem brain tissue: A study of the BrainNet Europe consortium","volume":"35","author":"Monoranu","year":"2009","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JAD-160320_ref43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2006.09.025","article-title":"Human postmortem tissue: What quality markers matter?","volume":"1123","author":"Stan","year":"2006","journal-title":"Brain Res"},{"key":"10.3233\/JAD-160320_ref44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000051214","article-title":"Neurones and their dendrites in frontotemporal dementia","volume":"10","author":"Ferrer","year":"1999","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-160320_ref45","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/jnnp.56.6.605","article-title":"Dementia of frontal lobe type: Neuropathology and immunohistochemistry","volume":"56","author":"Mann","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-160320_ref46","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0022-3565(25)11149-X","article-title":"5-hydroxytryptamine1A but not 5-hydroxytryptamine2 receptors are enriched on neocortical pyramidal neurons destroyed by intrastriatal volkensin","volume":"261","author":"Francis","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.3233\/JAD-160320_ref47","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0166-2236(92)90015-Z","article-title":"Traditional pharmacotherapy may succeed in Alzheimer\u2019s disease","volume":"15","author":"Bowen","year":"1992","journal-title":"Trends Neurosci"},{"key":"10.3233\/JAD-160320_ref48","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0006-8993(86)90348-3","article-title":"Induced homotypic sprouting of serotonergic fibers in hippocampus. II. An immunocytochemistry study","volume":"373","author":"Zhou","year":"1986","journal-title":"Brain Res"},{"key":"10.3233\/JAD-160320_ref49","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000051219","article-title":"Neurochemical features of frontotemporal dementia","volume":"10","author":"Procter","year":"1999","journal-title":"Dement Geriatr Cogn Dis"},{"key":"10.3233\/JAD-160320_ref50","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s004010000293","article-title":"Frontotemporal dementia: Evidence for impairment of ascending serotonergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method","volume":"101","author":"Yang","year":"2001","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-160320_ref51","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-4615-1853-2_10","volume-title":"Neurotransmitters in the human brain. Advances in behavioral biology","author":"Baker","year":"1995"},{"key":"10.3233\/JAD-160320_ref52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0079-6123(08)63799-1","article-title":"Afferent regulation of locus coeruleus neurons: Anatomy, physiology and pharmacology","volume":"88","author":"Aston-Jones","year":"1991","journal-title":"Prog Brain Res"},{"key":"10.3233\/JAD-160320_ref53","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0306-4522(87)90326-5","article-title":"Serotonin receptors in the human brain\u2013III. Autoradiographic mapping of serotonin-1 receptors","volume":"21","author":"Pazos","year":"1987","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-160320_ref54","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/archneur.1991.00530190064017","article-title":"Alterations in brain monoamine oxidase activity in aging, Alzheimer\u2019s disease, and Pick\u2019s disease","volume":"48","author":"Sparks","year":"1991","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-160320_ref55","first-page":"211","article-title":"Catecholamines","author":"Kuhar","year":"2006","journal-title":"Basic Neurochemistry: Molecular, Cellular and Medical Aspects"},{"key":"10.3233\/JAD-160320_ref56","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/npp.1993.68","article-title":"On the value of measuring dopamine, norepinephrine and their metabolites in schizophrenia","volume":"8","author":"Kahn","year":"1993","journal-title":"Neuropsychopharmacology"},{"key":"10.3233\/JAD-160320_ref57","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0022-510X(80)90205-1","article-title":"Neurochemical observations in a case of Pick\u2019s disease","volume":"48","author":"Yates","year":"1980","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-160320_ref58","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/0278-5846(95)00264-2","article-title":"A juvenile case of frontotemporal dementia: Neurochemical and neuropathological investigations","volume":"19","author":"Nagaoka","year":"1995","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.3233\/JAD-160320_ref59","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbr.2008.02.023","article-title":"The role of 5-HT(1A) receptors in learning and memory","volume":"195","author":"Ogren","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.3233\/JAD-160320_ref60","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0006-3223(01)01235-5","article-title":"Noradrenergic changes, aggressive behavior, and cognition in patients with dementia","volume":"51","author":"Matthews","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-160320_ref61","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00401-006-0138-9","article-title":"Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: Classification and relation to clinical phenotype","volume":"112","author":"Mackenzie","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-160320_ref62","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.neurobiolaging.2012.03.009","article-title":"Frontal asymmetry in behavioral variant frontotemporal dementia: Clinicoimaging and pathogenetic correlates","volume":"34","author":"Whitwell","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160320_ref63","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.neurobiolaging.2012.09.010","article-title":"Prazosin, an \u03b11-adrenoreceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer\u2019s disease","volume":"34","author":"Katsouri","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160320_ref64","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/bcpt.12090","article-title":"Pharmacological characterisation of a structurally novel \u03b12C-adrenoceptor antagonist ORM-10921 and its effects in neuropsychiatric models","volume":"113","author":"Sallinen","year":"2013","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.3233\/JAD-160320_ref65","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF02246578","article-title":"The \u03b12 antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type","volume":"123","author":"Coull","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.3233\/JAD-160320_ref66","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/rheumatology\/ket421","article-title":"A double-blind, randomized, placebo-controlled crossover trial of the \u03b12C-adrenoceptor antagonist ORM-12741 for prevention of cold-induced vasospasm in patients with systemic sclerosis","volume":"53","author":"Herrick","year":"2014","journal-title":"Rheumatology (Oxford)"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-160320","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:03:10Z","timestamp":1777370590000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-160320"}},"subtitle":[],"editor":[{"given":"Gwenn","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,3]]},"references-count":66,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-160320","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,3]]}}}